BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laursen NS, Pedersen DV, Gytz H, Zarantonello A, Bernth Jensen JM, Hansen AG, Thiel S, Andersen GR. Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement System. Front Immunol 2020;11:1504. [PMID: 32849513 DOI: 10.3389/fimmu.2020.01504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zarantonello A, Pedersen H, Laursen NS, Andersen GR. Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies. Biomolecules 2021;11:298. [PMID: 33671302 DOI: 10.3390/biom11020298] [Reference Citation Analysis]
2 Son M. Understanding the contextual functions of C1q and LAIR-1 and their applications. Exp Mol Med 2022;54:567-72. [PMID: 35562585 DOI: 10.1038/s12276-022-00774-4] [Reference Citation Analysis]
3 Bernth Jensen JM, Skeldal S, Petersen MS, Møller BK, Hoffmann S, Jensenius JC, Skov Sørensen UB, Thiel S. The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity. Immunology 2021;162:434-51. [PMID: 33340093 DOI: 10.1111/imm.13297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jensen RK, Pedersen H, Lorentzen J, Laursen NS, Vorup-Jensen T, Andersen GR. Structural insights into the function-modulating effects of nanobody binding to the integrin receptor αMβ2. J Biol Chem 2022;:102168. [PMID: 35738398 DOI: 10.1016/j.jbc.2022.102168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]